Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human MMP-8 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB9081
This item is not returnable.
View return policy
Description
MMP-8 Monoclonal specifically detects MMP-8 in Human samples. It is validated for ELISA, Immunohistochemistry, Intracellular Staining by Flow Cytometry, CyTOF-ready.Specifications
MMP-8 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CLG1HNC, Collagenase 2, EC 3.4.24, EC 3.4.24.34, matrix metallopeptidase 8 (neutrophil collagenase), matrix metalloproteinase 8 (neutrophil collagenase), Matrix metalloproteinase-8, MMP8, MMP-8, neutrophil collagenase, PMNL collagenase, PMNL-CL | |
Mouse | |
Protein A or G purified from ascites | |
RUO | |
4317 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
ELISA, Immunohistochemistry, Flow Cytometry, CyTOF | |
100608 | |
ELISA, Immunohistochemistry 8-25 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready | |
AAZ38714 | |
MMP8 | |
Mouse myeloma cell line NS0-derived recombinant human MMP-8 Phe21-Gly467 Accession # AAZ38714 | |
500 μg | |
Primary | |
Detects both pro and active forms of human MMP-8 in Western blots. In Western blots, no cross-reactivity with recombinant human (rh) MMP-1, -2, -3, -7, -9, -10, -12, or -13 is observed. | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction